Fully Automated Clinical Chemistry Analyzer - India CDSCO Medical Device Registration

Fully Automated Clinical Chemistry Analyzer is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000015_c2306a1f799ce8c8daa15a0aac630bfc_e390a938644cccbf67bd0d937ce3ae6f. This device is marketed under the brand name QDx Urilyzer 100 pro. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class A. The approving authority is Kokan Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class A

Fully Automated Clinical Chemistry Analyzer

UID: MFG/IVD/2022/000015_c2306a1f799ce8c8daa15a0aac630bfc_e390a938644cccbf67bd0d937ce3ae6f

Brand Name

QDx Urilyzer 100 pro

License Holder

DiaSys Diagnostics India Private Limited

Device Class

Class A

Approving Authority

Kokan Division

Product Information

The product is a fully automated clinical chemistry analyzer for quantitative analysis of chemical components in human samples (QDx Urilyzer 100 pro), which can assist in the diagnosis of normal people and patients with related diseases. The product has no independent measuring function and uses the supporting biochemical reagent kit manufactured by DiaSys to finish testing. The detectable indicators include: liver function, renal function, ion-metabolization, blood sugar, blood fat, myocardium enzymogram, immunity and other items. For professional use only